- Home
- SMHI vs FATE Comparison
SMHI vs FATE Comparison
Compare SMHI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- FATE
- Stock Information
- Founded
- SMHI 1989
- FATE 2007
- Country
- SMHI United States
- FATE United States
- Employees
- SMHI N/A
- FATE N/A
- Industry
- SMHI Marine Transportation
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMHI Consumer Discretionary
- FATE Health Care
- Exchange
- SMHI Nasdaq
- FATE Nasdaq
- Market Cap
- SMHI 142.2M
- FATE 133.0M
- IPO Year
- SMHI N/A
- FATE 2013
- Fundamental
- Price
- SMHI $5.34
- FATE $1.21
- Analyst Decision
- SMHI
- FATE Hold
- Analyst Count
- SMHI 0
- FATE 8
- Target Price
- SMHI N/A
- FATE $4.14
- AVG Volume (30 Days)
- SMHI 98.1K
- FATE 1.8M
- Earning Date
- SMHI 04-30-2025
- FATE 05-13-2025
- Dividend Yield
- SMHI N/A
- FATE N/A
- EPS Growth
- SMHI N/A
- FATE N/A
- EPS
- SMHI N/A
- FATE N/A
- Revenue
- SMHI $264,089,999.00
- FATE $13,335,000.00
- Revenue This Year
- SMHI $4.13
- FATE N/A
- Revenue Next Year
- SMHI $8.55
- FATE N/A
- P/E Ratio
- SMHI N/A
- FATE N/A
- Revenue Growth
- SMHI N/A
- FATE 105.85
- 52 Week Low
- SMHI $3.63
- FATE $0.66
- 52 Week High
- SMHI $15.36
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- SMHI 57.17
- FATE 53.44
- Support Level
- SMHI $4.84
- FATE $1.12
- Resistance Level
- SMHI $5.54
- FATE $1.38
- Average True Range (ATR)
- SMHI 0.25
- FATE 0.12
- MACD
- SMHI 0.04
- FATE 0.01
- Stochastic Oscillator
- SMHI 71.43
- FATE 62.22
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.